South Carolina General Assembly
122nd Session, 2017-2018

Download This Bill in Microsoft Word format

Indicates Matter Stricken
Indicates New Matter

A169, R182, H4600

STATUS INFORMATION

General Bill
Sponsors: Reps. Huggins, Bedingfield, Alexander, Dillard, Douglas, Erickson, Fry, Henderson, Hewitt, Ridgeway, Spires, West, Norrell, Weeks, Rutherford and Atwater
Document Path: l:\council\bills\cc\15172vr18.docx

Introduced in the House on January 10, 2018
Introduced in the Senate on March 21, 2018
Last Amended on March 20, 2018
Passed by the General Assembly on April 26, 2018
Governor's Action: May 3, 2018, Signed

Summary: Opioid antidote, prescriptions to community organizations

HISTORY OF LEGISLATIVE ACTIONS

     Date      Body   Action Description with journal page number
-------------------------------------------------------------------------------
   1/10/2018  House   Introduced and read first time (House Journal-page 56)
   1/10/2018  House   Referred to Committee on Medical, Military, Public and 
                        Municipal Affairs (House Journal-page 56)
    3/8/2018  House   Committee report: Favorable with amendment Medical, 
                        Military, Public and Municipal Affairs 
                        (House Journal-page 5)
   3/20/2018  House   Amended (House Journal-page 23)
   3/20/2018  House   Read second time (House Journal-page 23)
   3/20/2018  House   Roll call Yeas-100  Nays-0 (House Journal-page 24)
   3/21/2018  House   Read third time and sent to Senate (House Journal-page 8)
   3/21/2018  Senate  Introduced and read first time (Senate Journal-page 5)
   3/21/2018  Senate  Referred to Committee on Medical Affairs 
                        (Senate Journal-page 5)
   4/19/2018  Senate  Committee report: Favorable Medical Affairs 
                        (Senate Journal-page 10)
   4/25/2018  Senate  Read second time (Senate Journal-page 25)
   4/25/2018  Senate  Roll call Ayes-43  Nays-0 (Senate Journal-page 25)
   4/26/2018  Senate  Read third time and enrolled (Senate Journal-page 17)
    5/1/2018          Ratified R 182
    5/3/2018          Signed By Governor
   5/11/2018          Effective date 05/03/18
   5/14/2018          Act No. 169

View the latest legislative information at the website

VERSIONS OF THIS BILL

1/10/2018
3/8/2018
3/20/2018
4/19/2018

(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)

(A169, R182, H4600)

AN ACT TO AMEND THE CODE OF LAWS OF SOUTH CAROLINA, 1976, BY ADDING SECTION 44-130-70 SO AS TO AUTHORIZE PHARMACISTS TO PRESCRIBE OPIOID ANTIDOTES TO CERTAIN COMMUNITY ORGANIZATIONS TO DISTRIBUTE TO A PERSON AT RISK OF EXPERIENCING AN OPIOID-RELATED OVERDOSE OR TO A CAREGIVER OF SUCH A PERSON; AND TO AMEND SECTION 44-130-20, RELATING TO TERMS DEFINED IN THE SOUTH CAROLINA OVERDOSE PREVENTION ACT, SO AS TO ADD A DEFINITION FOR "COMMUNITY DISTRIBUTOR".

Be it enacted by the General Assembly of the State of South Carolina:

Overdose Prevention Act, distributor of opioid antidotes by community organizations

SECTION    1.    Chapter 130, Title 44 of the 1976 Code is amended by adding:

"Section 44-130-70.    (A)    A prescriber acting in good faith and exercising reasonable care may directly or by standing order prescribe an opioid antidote to a community distributor for the purpose of distributing the opioid antidote to:

(1)    a person at risk of experiencing an opiate-related overdose; or

(2)    a caregiver of a person at risk of experiencing an opiate-related overdose.

(B)    A pharmacist may dispense an opioid antidote to a community distributor pursuant to a prescription or standing order issued in accordance with this section.

(C)(1)    A community distributor acting in good faith may distribute an opioid antidote:

(a)    obtained pursuant to a written prescription or standing order issued in accordance with this section; and

(b)    pursuant to a written joint protocol issued by the Board of Medical Examiners and the Board of Pharmacy.

(2)    Not later than six months after passage of this act, the Board of Medical Examiners and the Board of Pharmacy must issue a written joint protocol to authorize a community distributor to distribute an opioid antidote without a patient-specific written order or prescription to a person at risk of experiencing an opioid-related overdose or to a caregiver of such a person, and without the requirement for a pharmacist to dispense the opioid antidote.

(3)    The Board of Medical Examiners and the Board of Pharmacy must appoint an advisory committee to advise and assist in the development of the joint protocol for their consideration. The membership of the committee must include, but not be limited to, a representative of the Department of Health and Environmental Control, a representative of the Department of Alcohol and Other Drug Abuse Services, and health care professionals licensed in the State.

(4)    For purposes of this subsection, 'caregiver' means a person who is not at risk of an opioid overdose but who, in the judgment of the community distributor, may be in a position to assist another individual during an overdose.

(D)    A community distributor that distributes an opioid antidote in accordance with the provisions of this section is not as a result of an act or omission subject to civil or criminal liability."

Overdose Prevention Act, definition of community distributor

SECTION    2.    Section 44-130-20 of the 1976 Code is amended to read:

"Section 44-130-20.    For purposes of this chapter:

(1)    'Caregiver' means a person who is not at risk of an opioid overdose but who, in the judgment of a physician, may be in a position to assist another individual during an overdose and who has received patient overdose information as required by Section 44-130-30 on the indications for and administration of an opioid antidote.

(2)    'Community distributor' means an organization, either public or private, which provides substance use disorder assistance and services, such as counseling, homeless services, advocacy, harm reduction, alcohol and drug screening, and treatment to individuals at risk of experiencing an opioid-related overdose.

(3)    'Department' means the Department of Health and Environmental Control.

(4)    'Drug overdose' means an acute condition including, but not limited to, physical illness, coma, mania, hysteria, or death resulting from the consumption or use of a controlled substance or other substance with which a controlled substance was combined and that a layperson would reasonably believe to require medical assistance.

(5)    'First responder' means an emergency medical services provider, a law enforcement officer, or a fire department worker directly engaged in examining, treating, or directing persons during an emergency.

(6)    'Medical assistance' means professional medical services that are provided to a person experiencing a drug overdose.

(7)    'Opioid antidote' means naloxone hydrochloride or other similarly acting drug approved by the United States Food and Drug Administration for the treatment of an opioid overdose.

(8)    'Pharmacist' means an individual licensed pursuant to Chapter 43, Title 40 to engage in the practice of pharmacy.

(9)    'Prescriber' means a physician licensed pursuant to Chapter 47, Title 40, an advanced practice registered nurse licensed pursuant to Chapter 33, Title 40 and prescribing in accordance with the requirements of that chapter, and a physician assistant licensed pursuant to Article 7, Chapter 47, Title 40 and prescribing in accordance with the requirements of that article."

Time effective

SECTION    3.    This act takes effect upon approval by the Governor.

Ratified the 1st day of May, 2018.

Approved the 3rd day of May, 2018.

__________


This web page was last updated on May 30, 2018 at 9:45 AM